Sugar Derivatives TRIZ Cases

Soluble alkyl-chain supports enable homogeneous oligonucleotide synthesis, improving yield, purity, and scale beyond solid-phase limits.

A stabilized quencher with sulfonate and reactive groups improves aqueous storage, biomolecule binding, and nucleic acid detection sensitivity.

By linking a CD73 inhibitor to an Fc domain, this case improves metabolic stability while blocking CD73 and activating phagocytic immune functions.

A new 2′-hydroxyl protecting group and glycoside intermediate improve RNA solid-phase synthesis yield and purity.

Selective ribose protection and precipitation enable liquid-phase oligonucleotide synthesis with better scale-up, yield, and reaction monitoring.

Hydrophobic-tagged Im-m7GDP capping enables scalable chemical synthesis of highly pure, stable 5′-capped oligonucleotides.

Non-adenine bases inserted into poly-A sequences prevent shortening in bacteria and support more stable, efficient target protein expression.

ASGPR-binding degraders selectively remove pathogenic anti-β1AR antibodies in hepatocytes, easing DCM symptoms without broad IgG depletion side effects.

Thermal cycling separates cleavable and non-cleavable probe signals in one channel, expanding nucleic acid multiplexing without spectral deconvolution.

Running RNA capping at 40-60°C raises yield on structured RNAs while lowering enzyme demand and reducing purification steps.

Reverse irradiation deprotects and caps non-target DNA regions before target coupling, reducing diffraction-driven synthesis errors.

Polar group tuning and carrier formulations improve GPCR ligand solubility, stability, and tissue delivery without losing receptor activity.

Antibody-linked anthracycline payloads improve tumor accumulation and cancer cell killing while reducing cardiotoxicity and off-target toxicity.

Fluoride-ion deprotection under low-oxygen inert gas improves nucleic acid oligomer purity while simplifying ribose hydroxy group removal.

Neomycin-based conjugates suppress glioblastoma stemness and make tumor cells more responsive to chemotherapy and radiotherapy.

Fluoride-ion deprotection with a radical inhibitor combines cleavage and hydroxy-group removal to improve nucleic acid oligomer purity and synthesis efficiency.

Immobile Holliday junction analogs let DNA scaffolds escape parallel path limits and assemble complex 2D and 3D wireframe lattices.

Using phosphate-activated nucleotides streamlines polyphosphorylated nucleoside synthesis, cutting steps, raw material cost, and yield loss.

Covalent-linker nucleotide analogues enable precise base detection and clean 3′-OH regeneration for longer, continuous SBS sequencing.

Client-side compiled database logic shifts indexing and query control off the server, reducing redeployment burden and performance degradation.

An abasic probe covalently links to target guanine under controlled pH and NaCNBH3, improving sequence selectivity and signal stability.

Specific RMA-linked monomers improve dsRNA gene silencing by tuning oligonucleotide structure for stronger target gene inhibition.

Removable identifier moieties and protecting groups cut residual-tag noise in sequencing by synthesis and help extend read length.

Radio- and fluorescence-labeled CD73 inhibitors improve solid tumor imaging while enabling target-specific diagnosis and therapy.

Modified STOPS oligonucleotides use LNA and phosphorothioation to improve HBV and HDV response consistency and antiviral potency.

Deoxyribose linkers separate fluorescent moieties in polymeric dyes to curb intramolecular quenching and deliver brighter analyte detection.

Controlled recrystallization creates a stable hemihydrate crystal form that reduces hygroscopicity and preserves antiviral drug effectiveness.

Countercurrent flow in a trickle bed boosts gas-liquid-solid mass transfer, cutting hydrogen pressure and use while sustaining sugar alcohol yield.

By converting glucose into keto intermediates that favor keto-furanose tautomers, this case improves furan synthesis yield and avoids unstable HMF isolation.

Precipitation plus tangential flow filtration captures mRNA while removing aborted RNA and enzyme reagents for high-purity scale-up.

Isolated Balanophora dihydrochalcones boost sweetness and mask bitterness, astringency, and licorice notes in low-calorie sweetener blends.

Major-groove nucleoside modifications reduce innate immune binding and genomic damage risk while improving protein expression efficiency.

PNA oligomers and donor-loaded nanoparticles target the β-globin mutation to enable site-specific repair without donor-matching limits.

Targeted MYOT, FLNC, and MYOZ3 mutation testing enables earlier, more accurate diagnosis of inherited equine myopathies.

Modified internucleoside linking groups improve antisense nuclease resistance, tolerability, pharmacokinetics, and therapeutic index.

Sugar-derivatized imidazolines adsorb on metal and form hydrophobic films to curb aqueous corrosion with lower environmental impact.

These thiourea and urea trehalose compounds activate Mincle to drive Th1/Th17 vaccine responses while avoiding the high reactogenicity of TDM.

Targeting m6A writers, erasers, and readers helps sensitize tumors to immunotherapy while reducing cancer stem cell populations.

Purified ent-atisene diterpene glycosides from Stevia improve sweetness while reducing bitterness and lingering aftertaste in consumables.

Using pentafluorophenyl ester branching groups and palladium catalysis, this case improves reactive conjugate cluster purity and yield while cutting cost.

Adsorption resin and activated carbon remove furfural and 5-HMF upstream in L-arabinose production, improving purity and product safety.

Mechanical milling replaces bulk solvents in oligonucleotide synthesis, cutting chemical waste while enabling rapid internucleotide coupling.

Recombinant human anti-VZV antibodies replace scarce blood-derived immunoglobulins while neutralizing infection for prevention and treatment.

Chiral P(V) reagents enable direct control of phosphorus stereochemistry, avoiding diastereomer separation in oligonucleotide and C–P bond synthesis.

Novel Formula-based CD73 inhibitors block enzyme activity to address immune evasion, therapy resistance, and limited treatment options.

Enzymatic, base, and photo-cleavable linker strategies release surface-bound polynucleotides with higher yield and less sequence damage.

A rigid cyclic phosphonate locks 5′ siRNA conformation to preserve phosphatase resistance while strengthening Ago2 binding and activity.

DNA copy number analysis of canine chromosomes 2, 16, and 31 helps distinguish histiocytic malignancy from lymphoma and hemangiosarcoma.

By cutting repeated column chromatography, this GalNAc precursor route improves yield and lowers production cost while preserving purity.

Cyclic phosphate prodrugs protect gemcitabine through the gut, enabling liver release with better oral bioavailability and lower intestinal toxicity.